Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(25R)-Spirosta-1,4-dien-3-one is a naturally occurring steroidal compound belonging to the spirostane family, characterized by its unique carbon skeleton structure. This specific compound features a 1,4-diene system and a ketone functional group at the C-3 position. It is found in various plant species and has been studied for its potential biological activities, such as anti-inflammatory and cytotoxic effects. The (25R)-configuration indicates the chirality of the molecule, which is crucial for its interactions with biological targets. Research on (25R)-Spirosta-1,4-dien-3-one and its derivatives may lead to the development of new therapeutic agents, but further studies are needed to fully understand its properties and potential applications.

2137-22-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 2137-22-6 Structure
  • Basic information

    1. Product Name: (25R)-Spirosta-1,4-dien-3-one
    2. Synonyms: (25R)-Spirosta-1,4-dien-3-one;1-Dehydrodiosgenone
    3. CAS NO:2137-22-6
    4. Molecular Formula: C27H38O3
    5. Molecular Weight: 410.58882
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 2137-22-6.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 530.43°C at 760 mmHg
    3. Flash Point: 267.142°C
    4. Appearance: /
    5. Density: 1.128g/cm3
    6. Vapor Pressure: 0mmHg at 25°C
    7. Refractive Index: 1.558
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: (25R)-Spirosta-1,4-dien-3-one(CAS DataBase Reference)
    11. NIST Chemistry Reference: (25R)-Spirosta-1,4-dien-3-one(2137-22-6)
    12. EPA Substance Registry System: (25R)-Spirosta-1,4-dien-3-one(2137-22-6)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 2137-22-6(Hazardous Substances Data)

2137-22-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 2137-22-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,1,3 and 7 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 2137-22:
(6*2)+(5*1)+(4*3)+(3*7)+(2*2)+(1*2)=56
56 % 10 = 6
So 2137-22-6 is a valid CAS Registry Number.
InChI:InChI=1/C27H40O3/c1-16-7-12-27(29-15-16)17(2)24-23(30-27)14-22-20-6-5-18-13-19(28)8-10-25(18,3)21(20)9-11-26(22,24)4/h13,16-17,20-24H,5-12,14-15H2,1-4H3/t16-,17+,20-,21+,22+,23+,24+,25+,26+,27-/m1/s1

2137-22-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name (25r)-spirosta-1,4-dien-3-one,1-dehydro

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2137-22-6 SDS

2137-22-6Downstream Products

2137-22-6Relevant articles and documents

Design, synthesis, and biological evaluation of diosgenin-indole derivatives as dual-functional agents for the treatment of Alzheimer's disease

Zhou, Li-Cheng,Liang, Ying-Fan,Huang, Yi,Yang, Gui-Xiang,Zheng, Lu-Lu,Sun, Jia-Min,Li, Yang,Zhu, Fu-Li,Qian, He-Wen,Wang, Rui,Ma, Lei

, (2021)

The complex pathogenesis of Alzheimer's disease (AD) has become a major obstacle in its treatment. An effective approach is to develop multifunctional agents that simultaneously target multiple pathological processes. Here, a series of diosgenin-indole compounds were designed, synthesized and evaluated for their neuroprotective effects against H2O2 (hydrogen peroxide), 6-OHDA (6-hydroxydopamine) and Aβ (beta amyloid) damages. Preliminary structure-activities relationship revealed that the introduction of indole fragment and electron-donating group at C-5 on ring indole could be beneficial for neuroprotective activities. Results indicated that compound 5b was the most promising candidate against cellular damage induced by H2O2 (52.9 ± 1.9%), 6-OHDA (38.4 ± 2.4%) and Aβ1-42 (54.4 ± 2.7%). Molecular docking study suggested the affinity for 5b bound to Aβ1-42 was ?40.59 kcal/mol, which revealed the strong binding affinity of 5b to Aβ1-42. The predicted values of brain/blood partition coefficient (?0.733) and polar surface area (85.118 ?2) indicated the favorable abilities of BBB permeation and absorption of 5b. In addition, 5b significantly decreased ROS (reactive oxygen species) production induced by H2O2. In the following in vivo experiment, 5b obviously attenuated memory and learning impairments of Aβ-injected mice. In summary, compound 5b could be considered as a promising dual-functional neuroprotective agent against AD.

Preparations of heterospirostanols and their pharmacological activities

Quan, Hang-Ji,Koyanagi, Jyunichi,Ohmori, Koichi,Uesato, Shinichi,Tsuchido, Tetsuaki,Saito, Setsuo

, p. 659 - 669 (2002)

(3β,20S,22S,25R)-22-Thiospirosol-5-en-3-ol (9) and (3β,20S,22S,25R)-22-seleno-spirosol-5-en-3-ol (11) were prepared from diosgenin (3) via 26-iodopseudodiosgenin (6) as a key intermediate. Diosgenone (15), solasodinone (16), (20S,22S,25R)-22-thio-spirosol

The efficient Δ1-dehydrogenation of a wide spectrum of 3-ketosteroids in a broad pH range by 3-ketosteroid dehydrogenase from Sterolibacterium denitrificans

Wojtkiewicz, Agnieszka M.,Wójcik, Patrycja,Procner, Magdalena,Flejszar, Monika,Oszajca, Maria,Hocho?owski, Mateusz,Tataruch, Mateusz,Mruga?a, Beata,Janeczko, Tomasz,Szaleniec, Maciej

, (2020)

Cholest-4-en-3-one Δ1-dehydrogenase (AcmB) from Sterolibacterium denitrificans, a key enzyme of the central degradation pathway of cholesterol, is a protein catalyzing Δ1-dehydrogenation of a wide range of 3-ketosteroids. In this study, we demonstrate the application of AcmB in the synthesis of 1-dehydro-3-ketosteroids and investigate the influence of reaction conditions on the catalytic performance of the enzyme. The recombinant AcmB expressed in E. coli BL21(DE3)Magic exhibits a broad pH optimum and pH stability in the range of 6.5 to 9.0. The activity-based pH optimum of AcmB reaction depends on the type of electron acceptor (2,6-dichloroindophenol - DCPIP, phenazine methosulfate - PMS or potassium hexacyanoferrate - K3[Fe(CN)6]) used in the biocatalytic process yielding the best kinetic properties for the reaction with a DCPIP/PMS mixture (kcat/Km = 1.4·105 s-1·M-1 at pH 9.0) followed by DCPIP (kcat/Km = 1.0·105 s-1·M-1 at pH = 6.5) and K3[Fe(CN)6] (kcat/Km = 0.5·102 s-1·M-1 at pH = 8.0). The unique feature of AcmB is its capability to convert both testosterone derivatives (C20–C22) as well as steroids substituted at C17 (C27-C30) such as cholest-4-en-3-one or (25R)-spirost-4-en-3-one (diosgenone). Apparent steady-state kinetic parameters were determined for both groups of AcmB substrates. In a batch reactor synthesis, the solubility of water-insoluble steroids was facilitated by the addition of a solubilizer, 2-hydroxypropyl-β-cyclodextrin, and organic co-solvent, 2-methoxyethanol. Catalytic properties characterization of AcmB was tested in fed-batch reactor set-ups, using 0.81 μM of isolated enzyme, PMS and aerobic atmosphere resulting in >99% conversion of the C17–C20 3-ketosteroids within 2 h. Finally, the whole cell E. coli system with recombinant enzyme was demonstrated as an efficient biocatalyst in the synthesis of 1-dehydro-3-ketosteroids.

Twin drug design, synthesis and evaluation of diosgenin derivatives as multitargeted agents for the treatment of vascular dementia

Yang, Gui-Xiang,Sun, Jia-Min,Zheng, Lu-Lu,Zhang, Li,Li, Jie,Gan, Hai-Xian,Huang, Yan,Huang, Jin,Diao, Xing-Xing,Tang, Yun,Wang, Rui,Ma, Lei

, (2021)

A novel series of multitargeted molecules were designed and synthesized by combining the pharmacological role of cholinesterase inhibitor and antioxidant of steroid as potential ligands for the treatment of Vascular Dementia (VD). The oxygen-glucose deprivation (OGD) model was used to evaluate these molecules, among which the most potent compound ML5 showed the highest activity. Firstly, ML5 showed appropriate inhibition of cholinesterases (ChEs) at orally 15 mg/kg in vivo. The further test revealed that ML5 promoted the nuclear translocation of Nrf2. Furthermore, ML5 has significant neuroprotective effect in vivo model of bilateral common carotid artery occlusion (BCCAO), significantly increasing the expression of Nrf2 protein in the cerebral cortex. In the molecular docking research, we predicted the ML5 combined with hAChE and Keap1. Finally, compound ML5 displayed normal oral absorption and it was nontoxic at 500 mg/kg, po, dose. We can draw the conclusion that ML5 could be considered as a new potential compound for VD treatment.

Steroid sapogenin derivative as well as preparation method and application thereof

-

Paragraph 0130-0132; 0135-0136, (2020/11/09)

The invention discloses a steroid sapogenin derivative represented by general formula (1), and a pharmaceutically acceptable salt and a pharmaceutical composition thereof. The steroid sapogenin derivative disclosed by the invention has a protective effect

Diosgenone synthesis, anti-malarial activity and QSAR of analogues of this natural product

Pabon, Adriana,Escobar, Gustavo,Vargas, Esteban,Cruz, Victor,Notario, Rafael,Blair, Silvia,Echeverri, Fernando

, p. 3356 - 3378 (2013/05/22)

Solanum nudum Dunal steroids have been reported as being antimalarial compounds; however, their concentration in plants is low, meaning that the species could be threatened by over-harvesting for this purpose. Swern oxidation was used for hemisynthesis of diosgenone (one of the most active steroidal sapogenin diosgenin compounds). Eighteen structural analogues were prepared; three of them were found to be more active than diosgenone (IC50 27.9 μM vs. 10.1 μM, 2.9 μM and 11.3 μM). The presence of a 4-en-3-one grouping in the A-ring of the compounds seems to be indispensable for antiplasmodial activity; progesterone (having the same functional group in the steroid A-ring) has also displayed antiplasmodial activity. Quantitative correlations between molecular structure and bioactivity were thus explored in diosgenone and several derivatives using well-established 3D-QSAR techniques. The models showed that combining electrostatic (70%) and steric (30%) fields can explain most variance regarding compound activity. Malarial parasitemia in mice became reduced by oral administration of two diosgenone derivatives.

Further study on synthesis and evaluation of 3,16,20-polyoxygenated steroids of marine origin and their analogs as potent cytotoxic agents

Bunyathaworn, Potjamarn,Boonananwong, Suthinee,Kongkathip, Boonsong,Kongkathip, Ngampong

experimental part, p. 432 - 444 (2010/06/13)

A series of new polyoxygenated steroid derivatives with various steroid skeleton moieties were synthesized. Antitumor activity of the compounds against three tumor cell lines (Breast cancer MCF7, lung cancer NCI and oral cancer KB) were evaluated. Compoun

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2137-22-6